Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2005
10/13/2005WO2004078994A3 Methods for detection of genetic disorders
10/13/2005WO2004074509A3 Reversible attachment of a membrane active polymer to a polynucleotide
10/13/2005WO2004072253A3 Human excitatory amino acid transporter-2 gene promoter and uses thereof
10/13/2005WO2004054436A3 Calcium-independent phospholipase a2 induces ischemic ventricular arrhythmias and decreases infarction size
10/13/2005WO2004008279A3 Computer user interface facilitating acquiring and analyzing of biological specimen traits
10/13/2005WO2003099779A3 Hemipteran muscarinic receptor
10/13/2005WO2003088919A3 Compositions and methods for diagnostics and therapeutics for hydrocephalus
10/13/2005WO2003078570A8 Multiple controls for molecular genetic analyses
10/13/2005WO2002014467A9 Cng2b: a putative human cyclic nucleotide-gated ion channel
10/13/2005US20050229280 Oak tree named 'qnstc'
10/13/2005US20050229277 Apple tree named 'PV 1027'
10/13/2005US20050229265 Insect ammunition vectors and methods of use to identify pesticide targets
10/13/2005US20050229260 Compound screens relating to insulin deficiency or insulin resistance
10/13/2005US20050228592 Method and device for partitioning a molecule
10/13/2005US20050228172 Identification and mapping of single nucleotide polymorphisms in the human genome
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050227918 Method for assaying susceptibility to cancer therapy in a subject by assaying for tumors of P53
10/13/2005US20050227917 Gene products differentially expressed in cancerous cells and their methods of use II
10/13/2005US20050227916 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/13/2005US20050227373 Method and device for high sensitivity detection of the presence of dna and other probes
10/13/2005US20050227356 Novel compositions and methods for genetic manipulation of Rhodococcus bacteria
10/13/2005US20050227351 Methods and compound protein molecules used for inducing cytotoxic cell-mediated immune response in a mammal against a pathogenic cell
10/13/2005US20050227346 Cultivation of dispersed mycobacteria
10/13/2005US20050227324 Comprise a single antigen binding arm and an Fc region; exhibits enhanced stability in vivo compared to a Fab antibody fragment
10/13/2005US20050227319 DNA sequences coding for enzymes capable of facilitating the synthesis of linear alpha-1,4 glucans in plants, fungi and microorganisms
10/13/2005US20050227317 Mammalian expression system
10/13/2005US20050227310 Fluorescence activated cell sorting using caged fluorescent molecule is selected from the group consisting of N-(DMNB-caged fluorescein)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine or 5-carboxyfluorescein-bis-(5-carboxymethoxy-2-nitrobenzyl) ether-alanine-carboxamide, succinimidyl ester
10/13/2005US20050227309 Optically-detectable enzyme substrates and their method of use
10/13/2005US20050227308 Method for detecting oxidized forms of soluble guanylate cyclase and a method for screening for activators of soluble guanylate cyclase having oxidized heme iron
10/13/2005US20050227307 2-hydroxyethidium, methods of preparation and uses thereof
10/13/2005US20050227306 Fluorescence polarization assay to detect protease cleavage
10/13/2005US20050227305 Methods for the identification of inhibitors of adenylosuccinate synthase as antibiotics
10/13/2005US20050227304 Methods for the identification of inhibitors of histidinol dehydrogenase as antibiotics
10/13/2005US20050227303 Method and composition for diagnosis of melanocytic lesions
10/13/2005US20050227302 Induction of apoptosis via ARTS-IAP complexes
10/13/2005US20050227300 Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors
10/13/2005US20050227292 Allergenic protein complex of natural rubber latex
10/13/2005US20050227289 Antibodies to erythropoietin receptor and uses thereof
10/13/2005US20050227287 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPSc
10/13/2005US20050227286 Method of preparing a standard diagnostic gene transcript pattern
10/13/2005US20050227285 Control of gene expression in eukaryotic cells
10/13/2005US20050227282 Human extracellular matrix-1
10/13/2005US20050227280 Proteases
10/13/2005US20050227279 Methods of using torsin proteins, to prevent protein misfolding and treat protein aggregation-associated disorders
10/13/2005US20050227278 Recursive categorical sequence assembly
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050227276 isolated nucleic acids; nucleotide sequences; codes genes; deecting moderators of kinase protein
10/13/2005US20050227275 Nucleic acid detection system
10/13/2005US20050227274 Detection method and detection apparatus of substance in biological sample
10/13/2005US20050227273 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
10/13/2005US20050227272 Isolated nucleic acid with polynucleotide encoding a polypeptide that interacts with I kappa B alpha probe; diagnosis or pre-diagnosis of Type 1 diabetes in an individual
10/13/2005US20050227271 Microarray having microarray identification information stored in the form of a spot, method of producing the microarray and method of using the microarray
10/13/2005US20050227270 Alternatively spliced isoforms of sodium channel, voltage gated, type XI, alpha (SCN11A)
10/13/2005US20050227269 Devices and methods for collection, storage and transportation of biological specimens
10/13/2005US20050227267 Method of identifying genetic regions associated with disease and predicting responsiveness to therapeutic agents
10/13/2005US20050227266 Biomarker:compound correlations in cancer diagnosis and therapy
10/13/2005US20050227265 Method for detection of promoter methylation status
10/13/2005US20050227264 Nucleic acid amplification with continuous flow emulsion
10/13/2005US20050227263 Method of performing PCR amplification on a microarray
10/13/2005US20050227262 polynucleotides that code for polypeptide comprising beta-ketoacyl synthase, acetyl transferase, dehydratase, methyltransferase, ketoreductase, and acyl carrier proteins; anticholesterol agents produced by Monascus
10/13/2005US20050227261 Method for sequencing-by-synthesis
10/13/2005US20050227260 Splicing factor target identification
10/13/2005US20050227259 Enzyme-free isothermal exponential amplification of nucleic acids and nucleic acid analog signals
10/13/2005US20050227258 Site selectively tagged and templated molecularly imprinted polymers for sensor applications
10/13/2005US20050227257 Double stranded linear nucleic acid probe and uses thereof
10/13/2005US20050227256 Sequence-specific inhibition of small RNA function
10/13/2005US20050227254 useful as labels when attached to biomolecules such as natural or modified polynucleotides, oligonucleotides, nucleosides, nucleotides, carbohydrates and peptides, comprising a fluorescent dyes; genetic probes
10/13/2005US20050227253 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
10/13/2005US20050227252 analysis using optical substrate having chemicals being bound to the substrate and portion of said substrate having diffraction grids, that provides an output optical signal when illuminated by an incident light signal, thet optical output signal is indicative of codes in the substrates
10/13/2005US20050227251 Method of purifying RNA binding protein-RNA complexes
10/13/2005US20050227250 Human Elk, a voltage-gated potassium channel subunit
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227247 Contacting a target nucleic acid sequence with PCR reagents of primers and a polymerase enzyme, and an oligonucleotide probe; hybridizing to a target polynucleotide sequence; a fluorescer molecule attached to a first end of the oligonucleotide and a quencher molecule
10/13/2005US20050227246 System for producing Synthetic Promoters
10/13/2005US20050227245 Reagents and methods for identifying and modulating expression of genes regulated by retinoids
10/13/2005US20050227244 Methods for genotyping polymorphisms in humans
10/13/2005US20050227241 Porous substrate plates and the use thereof
10/13/2005US20050227240 conjugated reporter compounds having a modified cyanine dye that is coupled to a nucleotide derivative through a linker; useful for nucleic acid sequence analysis, DNA chain-terminators in DNA synthesis
10/13/2005US20050227239 Microarray based affinity purification and analysis device coupled with solid state nanopore electrodes
10/13/2005US20050227238 Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
10/13/2005US20050227236 Mold infections
10/13/2005US20050227235 Methods for high fidelity production of long nucleic acid molecules with error control
10/13/2005US20050227234 Method for the simultaneous detection of hybridization and vaccination reactions and diagnostic uses thereof
10/13/2005US20050227233 Method for diagnosing and treating schizophrenia
10/13/2005US20050227232 Surface-energy gradient on a fluid-impervious surface and method of its creation using a mixed monolayer film
10/13/2005US20050227230 Detection of dna methylation
10/13/2005US20050227229 Multiple controls for molecular genetic analyses
10/13/2005US20050227228 Map3ks as modifiers of the p53 pathway and methods of use
10/13/2005US20050227227 Nucleic acid oligomers; protease, reverse transcriptase; labeled oligonucleotide that specifically hybridizes; determine appropriate treatment
10/13/2005US20050227226 Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
10/13/2005US20050227225 Stabilization of biomolecules in samples
10/13/2005US20050227222 Pathogen identification method
10/13/2005US20050227221 Methods and systems for evaluating and for comparing methods of testing tissue samples
10/13/2005US20050227220 Compositions and Methods for Evaluating and Designing Nuclear Receptor Ligands that Modulate Co-Regulator Affinity
10/13/2005US20050226892 Methods and compositions comprising bacteriophage nanoparticles
10/13/2005US20050226890 Tat-based vaccine compositions and methods of making and using same
10/13/2005US20050226884 Using monoclonal antibody as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders; immunotherapy
10/13/2005US20050226879 Methods and compositions related to inhibiting nuclear envelope breakdown
10/13/2005US20050226853 Skin substitutes and uses thereof
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
1 ... 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 ... 3003